Cannabis Rescheduling and Cannabis Jobs: What to Know

Since the passage of California’s Proposition 215 nearly three decades ago, the cannabis industry has waited for the federal government to catch up with state-level policy, and with reality. Despite widespread medical use, voter approval, and a multibillion-dollar regulated market, cannabis has remained classified alongside heroin and other Schedule I drugs.

The White House’s December 18 executive order signals a meaningful shift. While it stops short of federal legalization, the order directs Attorney General Pam Bondi to begin the process of rescheduling cannabis from Schedule I to Schedule III under the Controlled Substances Act. The change carries important implications for medical research, taxation, and critically, the cannabis workforce.

For cannabis executives, HR leaders, and senior professionals, the question isn’t whether legalization is imminent. It’s how cannabis rescheduling and cannabis jobs intersect to reshape hiring strategy, leadership recruitment, and long-term workforce stability as the industry moves toward greater federal alignment.

Why Hiring Shifts Begin Before Laws Are Finalized

In highly regulated industries, labor markets rarely wait for statutory certainty. Once an executive directive clarifies policy direction, companies often restructure well before rules are finalized. This is common in healthcare, financial services, and energy, where regulatory preparedness affects risk exposure, investor confidence, and operational continuity.

Cannabis is now entering a similar phase. Although the executive order does not itself change federal law, it sends a strong signal about where federal policy is headed. Many cannabis companies are already reassessing hiring plans, redefining leadership roles, and prioritizing long-term workforce planning as cannabis rescheduling and cannabis jobs become more closely linked. 

President Trump has instructed the Department of Justice to implement the order “in the most expeditious manner in accordance with federal law,” though the final timeline remains uncertain. Even so, organizations that wait for absolute clarity may find themselves behind competitors who prepare early.

Immediate Workforce Effects Companies Are Preparing For

A common misconception is that meaningful changes to the cannabis job market depend on full federal legalization. But, rescheduling alone could trigger immediate financial shifts, most notably through the potential elimination of Internal Revenue Code Section 280E.

Section 280E currently prevents cannabis businesses from deducting standard operating expenses such as payroll, rent, and utilities. If cannabis is moved to Schedule III, those restrictions would no longer apply, significantly improving cash flow for state-legal operators and accelerating the connection between cannabis rescheduling and cannabis jobs across regulated organizations. 

As Michael Bronstein, President of the American Trade Association for Cannabis and Hemp (ATACH), told Cannabis Business Times, rescheduling “brings long-overdue equal tax treatment by lifting draconian tax penalties on state-legal businesses, and allowing reinvestment in local jobs and communities”. While implementation timelines still matter, many organizations are already modeling budgets and headcount as though 280E relief is forthcoming, prompting a reassessment of talent needs.

New Opportunities, New Compliance Realities

Rescheduling does not eliminate federal oversight. Interstate commerce would remain illegal, and lawful prescription-based cannabis sales would require FDA approval. The Congressional Research Service has also reiterated that unlawful marijuana use and related convictions may continue to carry collateral consequences for employment, immigration, housing, education, and firearm possession.

The result is a more complex regulatory environment, not a simpler one. Cannabis employers may gain financial flexibility while facing heightened expectations around governance, reporting, and compliance. This dynamic is already influencing hiring priorities.

Rather than expanding plant-touching headcount, many organizations are shifting focus toward professionals with expertise in tax strategy, finance, compliance, and multi-state operations—skills that support durability in a more scrutinized landscape.

Roles Likely to See Increased Demand

As rescheduling progresses, job growth is expected to concentrate in corporate and ancillary functions that signal operational maturity and long-term stability. Roles likely to see increased demand include:

• Compliance and regulatory affairs professionals
• Finance, accounting, and tax leadership
• Multi-state operations and corporate governance roles
• Enterprise IT, ERP, and security professionals
• Corporate sales, partnerships, and strategic growth leaders

For senior professionals evaluating the industry, this shift highlights how cannabis rescheduling and cannabis jobs are evolving toward enterprise-level talent needs.

Executive Hiring and Leadership Maturity

Moving cannabis to Schedule III represents a major step toward modernizing the industry and reducing the stigma and legal risk long associated with Schedule I classification. Cresco Labs CEO Charlie Bachtell recently described rescheduling as “the first domino to fall, paving the way for cannabis to be normalized, respected and finally treated like any other U.S. industry. It will remove cannabis companies’ unfair tax burden, allowing operators to reinvest in new infrastructure and job growth in the communities we serve.”

For the first time, many cannabis employers can competitively recruit executive-level talent from adjacent sectors such as agriculture, healthcare, consumer packaged goods, and technology. Improved margins and clearer regulatory direction make leadership roles more viable for seasoned professionals seeking long-term stability.

What Employers Should Do Now

Organizations that prepare early stand to gain a meaningful advantage. Employers should audit internal teams to identify gaps that could limit future growth or regulatory readiness. Addressing those vulnerabilities now, before competition intensifies, can reduce risk and control hiring costs.

Talent strategies should prioritize expertise in law, accounting, quality assurance, human resources, research, and government regulatory affairs. For professionals, employer behavior matters more than headlines. Companies investing in governance, infrastructure, and experienced leadership are more likely to offer career stability as regulatory expectations evolve.

Plan Your Hiring Strategy with M&F Talent Before the Market Shifts

Cannabis rescheduling is already influencing how organizations approach leadership, compliance, and workforce planning. Companies that act early gain access to stronger executive and compliance talent, while those that wait may face higher costs and increased risk.

Mac & Fulton Talent Partners helps forward-thinking cannabis organizations build leadership teams that support regulatory readiness, operational discipline, and sustainable growth as the industry evolves. Contact us to learn more!